Skip to content

company

Chugai Pharmaceutical

Japanese drugmaker specialising in antibody engineering and biologics, majority-owned by Roche, and the originator of emicizumab.

Known aliases

  • Chugai

Relationships

No evidence-backed relationships are recorded.

Current clusters